Literature DB >> 35166921

Fluid balance assessment in pediatric hemodialysis patients by using whole-body bioimpedance spectroscopy (WB-BIS).

Ei E Khin1,2,3, Ayah Y Elmaghrabi1,2, Luis A Alvarado3, Vinai Modem4, Raymond Quigley5,6.   

Abstract

BACKGROUND: Fluid overload is a major factor in morbidity and mortality in dialysis patients. Whole-body bioimpedance spectroscopy (WB-BIS) is a noninvasive method for assessing fluid status. We hypothesized that fluid status measurement of changes in total body water (TBW), extracellular fluid (ECF), and intracellular fluid (ICF) by WB-BIS would correlate with the weight (Wt) changes before and after hemodialysis (HD) and the amount of ultrafiltration (UF) in pediatric HD patients. We also examined the relationship between the ECF percent of total body water (ECF%) and ECF/ICF ratio with the pre-HD systolic blood pressure percentile (SBP%ile).
METHODS: WB-BIS measurements were made both before and after HD on three separate occasions in each patient. Pre- and post-HD Wt, BP, and UF volumes were collected on the day of BIS measurement.
RESULTS: At total of 96 measurements were obtained from 16 HD patients. There were 6 females (mean age: 13.2 ± 4.5 yrs). UF correlated with changes in weight, TBW and ECF (p < 0.001) but not with ICF changes (p = 0.345). Pre-HD SBP%ile correlated with ECF%.
CONCLUSIONS: Our findings suggest that WB-BIS can be used to monitor the fluid status in pediatric HD patients. The fluid that is removed from the patient during the HD treatment primarily comes from the ECF and not the ICF. Mobilization of fluid from the ICF appears to be delayed. Patients with significantly higher pre-HD ECF% and ECF/ICF ratio had higher pre-HD systolic BP. A higher resolution version of the Graphical abstract is available as Supplementary information.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Entities:  

Keywords:  Bioimpedance spectroscopy (BIS); Fluid overload; Hemodialysis; Systolic BP

Mesh:

Year:  2022        PMID: 35166921     DOI: 10.1007/s00467-022-05469-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  30 in total

1.  Fluid volumes determination by impedance spectroscopy and hematocrit monitoring: application to pediatric hemodialysis.

Authors:  M Fenech; M Maasrani; M Y Jaffrin
Journal:  Artif Organs       Date:  2001-02       Impact factor: 3.094

2.  Pediatric end-stage renal disease: heart as a target.

Authors:  Mark M Mitsnefes
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

3.  Bioimpedance and Fluid Status in Children and Adolescents Treated With Dialysis.

Authors:  Gregorio P Milani; Jaap W Groothoff; Federica A Vianello; Emilio F Fossali; Fabio Paglialonga; Alberto Edefonti; Carlo Agostoni; Dario Consonni; Dewi van Harskamp; Johannes B van Goudoever; Henk Schierbeek; Michiel J S Oosterveld
Journal:  Am J Kidney Dis       Date:  2017-01-13       Impact factor: 8.860

Review 4.  Current state of bioimpedance technologies in dialysis.

Authors:  Peter Kotanko; Nathan W Levin; Fansan Zhu
Journal:  Nephrol Dial Transplant       Date:  2008-01-08       Impact factor: 5.992

5.  Chronic Fluid Overload and Mortality in ESRD.

Authors:  Carmine Zoccali; Ulrich Moissl; Charles Chazot; Francesca Mallamaci; Giovanni Tripepi; Otto Arkossy; Peter Wabel; Stefano Stuard
Journal:  J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 10.121

6.  Validation of estimates of total body water in pediatric dialysis patients by deuterium dilution.

Authors:  Susan R Mendley; Nancy L Majkowski; Dale A Schoeller
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

Review 7.  Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods.

Authors:  Michel Y Jaffrin; Hélène Morel
Journal:  Med Eng Phys       Date:  2008-08-03       Impact factor: 2.242

Review 8.  Hypertension and dialysis.

Authors:  Matthias P Hörl; Walter H Hörl
Journal:  Kidney Blood Press Res       Date:  2003       Impact factor: 2.687

9.  Cardiovascular mortality in children and young adults with end-stage kidney disease.

Authors:  R S Parekh; C E Carroll; R A Wolfe; F K Port
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

10.  Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010.

Authors:  Mark M Mitsnefes; Benjamin L Laskin; Mourad Dahhou; Xun Zhang; Bethany J Foster
Journal:  JAMA       Date:  2013-05-08       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.